IDEAYA Biosciences Inc
IDYA
NASDAQ
Biotechnology
$36.30
USD
-0.38 (-1.04%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $3.55B
Volume 435.0K
Revenue
$234.13M
TTM
+3244.7%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-175.02M
TTM
+47.3%
YoY
Operating Cash Flow
$-111.66M
TTM
+62.0%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 207.8 | 10.9 | 6.6 | 8.9 |
YoY Growth | — | — | +55.4% | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 207.8 | 10.9 | 6.6 | 8.9 |
Selling, General & Administrative | 14.6 | 16.4 | 18.8 | 19.4 | 22.5 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 88.8 | 99.4 | 105.4 | 115.1 | 131.1 |
Operating Income | -88.8 | 108.5 | -94.6 | -108.5 | -122.3 |
EBITDA | -88.1 | 109.1 | -93.8 | -107.9 | -121.6 |
Other Income / Expense | 11.3 | 10.8 | 11.3 | 10.0 | 9.8 |
Total Other Income / Expense | 11.3 | 10.8 | 11.3 | 10.0 | 9.8 |
Income Before Income Taxes | -77.5 | 119.2 | -83.3 | -98.5 | -112.5 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -77.5 | 119.2 | -83.3 | -98.5 | -112.5 |
Consolidated Net Income / Loss | -77.5 | 119.2 | -83.3 | -98.5 | -112.5 |
Net Income Attributable to Common Shareholders | -77.5 | 119.2 | -83.3 | -98.5 | -112.5 |
Basic EPS | -$0.88 | $1.35 | -$0.94 | -$1.11 | -$1.22 |
Diluted EPS | -$0.88 | $1.33 | -$0.95 | -$1.11 | -$1.22 |
Basic Shares Outstanding | 88.5M | 88.5M | 88.6M | 88.7M | 92.1M |
Diluted Shares Outstanding | 88.5M | 89.7M | 87.4M | 88.7M | 92.1M |